Pharma Business - December 2, 2014
Study: Biopharm Has High Risks, Uncertainty
A first-of-its kind comparison of the business risks confronting six key European industries revealed that the biopharmaceutical sector faces the highest level of risk and economic uncertainty. The study conducted by Deloitte and commissioned by Janssen, compared six industry sectors: the biopharmaceutical industry, commercial aircraft manufacturing, the automotive industry, consumer electronics, food manufacturing and generic […]
Clinical Trials - December 1, 2014
More Success for AZ Drug
Amgen and AstraZeneca have racked up their third straight Phase III win for brodalumab in plaque psoriasis, beating J&J’s Stelara in a head-to-head study. The news comes just two weeks after the pharmacy partners posted their latest positive results, positioning them for a run at regulators on both sides of the Atlantic. There are two key […]
Uncategorized - December 1, 2014
Monocl Receives Vinnova Grant
Monocl Software, a Life Science Intelligence company, has been awarded 2.7 MSEK through VINNOVA’s ‘Forska&Väx’ program. The funding will be used to enable a successful launch of MONOCL EGO in 2015. MONOCL EGO is a groundbreaking expert analytics tool designed to help professional users to find, assess and engage with relevant Life Science experts and […]
Uncategorized - December 1, 2014
Danish Database Underway
History professor Anne Løkke of the Saxo Institute at the University of Copenhagen and post-doc Bárbara A.Revuelta-Eugercios, who is in Denmark on a grant from Mobilexmidler, hope to build a national database from records that will make it possible to collate data in a computer program almost in the same way as health researchers work […]
Collaboration - November 27, 2014
Thermo Fisher, Samsung Collaborate on POC Solutions
Thermo Fisher Scientific Inc., which has offices in Finland, and Samsung Electronics Co., Ltd., have formed a strategic collaboration to jointly design, develop and market better point-of-care (POC) solutions in key applications. These include the detection of sepsis, drug abuse and therapeutic drug monitoring as well as the detection of cardiac problems and women’s health […]
Drug Development Pharma - November 27, 2014
Lundbeck Alcohol Addiction Drug Wins Approval in UK
Just two days after the Danish company’s Lundbeck CEO stepped down for an ethics lapse, the UK’s National Institute for Health and Care Excellence (NICE) gave Selincro (namelfene) approval in final draft guidance, meaning the country’s National Health Service will make funding available for the £42.42-per-14-tablet-pack medication within three months. “We are pleased to be able […]
